TOP HEADLINES

Featured Story

  • Illumina slaps Roche's Ariosa with a prenatal testing IP suit

    San Diego's Illumina announced that it is filing a patent infringement suit against Roche's Ariosa Diagnostics and its microarray-based Harmony Prenatal Test. The gene sequencing company accuses Ariosa of violating its '794 patent, called "Multiplex Nucleic Acid Reactions."

Sequenom stares down suit from Indian genomics firm

Sequenom is facing a lawsuit from an Indian genomics company for allegedly calling off a distribution agreement for its MassArray system, almost a year after the company handed the tool to Agena Bioscience through the sale of its Bioscience business.

Roche snags FDA CLIA waiver for rapid Strep A test

Roche got an FDA CLIA waiver for its rapid Strep A test, opening the door to expanded use of the product months after the agency signed off on the test.

Cypher teams up with biotech titan Celgene for companion diagnostics collaboration

San Diego's Cypher Genomics has attracted the attention of a biotech legionnaire, teaming up with industry heavyweight Celgene for a companion diagnostics project aimed at uncovering genetic biomarkers that help match patients to a suitable therapy.

Illumina slaps Roche's Ariosa with a prenatal testing IP suit

San Diego's Illumina announced that it is filing a patent infringement suit against Roche's Ariosa Diagnostics and its microarray-based Harmony Prenatal Test. The gene sequencing company accuses Ariosa of violating its '794 patent, called "Multiplex Nucleic Acid Reactions."

Broad Institute gets $10M to study genetics of cancer drug resistance

MIT and Harvard's collaborative Broad Institute just received a $10 million gift from the Gerstner Family Foundation to conduct research into cancer-resistant drugs using gene-editing technology and blood-based tumor biopsies.

MORE NEWS